Acorah Software Products - Accounts Production 16.4.675 false true false true No description of principal activity 21 March 2024 31 March 2025 31 March 2025 15582674 Mr ABDELRAHMAN MAHMOUD MOUSSA iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15582674 2024-03-20 15582674 2025-03-31 15582674 2024-03-21 2025-03-31 15582674 frs-core:CurrentFinancialInstruments 2025-03-31 15582674 frs-bus:PrivateLimitedCompanyLtd 2024-03-21 2025-03-31 15582674 frs-bus:FilletedAccounts 2024-03-21 2025-03-31 15582674 frs-bus:Micro-entities 2024-03-21 2025-03-31 15582674 frs-bus:AuditExempt-NoAccountantsReport 2024-03-21 2025-03-31 15582674 frs-bus:Director1 2024-03-21 2025-03-31
Registered number: 15582674
A&M PHARMA LTD
Unaudited Financial Statements
For the Period 21 March 2024 to 31 March 2025
UK TAX ACCOUNTANTS
2 Victor Street
Bradford
West Yorkshire
BD9 4RB
A&M PHARMA LTD
Balance Sheet
As At 31 March 2025
Balance Sheet
Registered number: 15582674

| 31 March 2025
--- | ---
|  | £
Current assets |  | 12,220
Creditors: Amounts Falling Due Within One Year |  | (10,243 )
NET CURRENT ASSETS |  | 1,977
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 1,977
Accruals and deferred income |  | (550 )
NET ASSETS |  | 1,427
CAPITAL AND RESERVES |  | 1,427

## Notes

1. General Information
A&M PHARMA LTD is a private company, limited by shares, incorporated in England & Wales, registered number 15582674 . The registered office is 21 GAINSBOROUGH COURT, LONDON, W4 4BD.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Mr ABDELRAHMAN MAHMOUD MOUSSA Director
02/10/2025